3 ms·
There is a lot of work that needs to be done to take a drug from "this works in a Petri dish" to "this is something that you can be prescribed for treatment." E
by jcranmer 7y ago
There is a lot of work that needs to be done to take a drug from "this works in a Petri dish" to "this is something that you can be prescribed for treatment." Empirically, about 90% of the compounds that start at that first level fail to make it to the last level. It also seems that academia is not any better than pharmaceuticals at either developing the first step or pushing something to the end.
- tempguy9999 7y ago> Empirically, about 90% of the compounds that start at that first level fail to make it to the last level That would be an incredible rate of success, depending on what 'first level' means. If you mean "reached human clinical trials", maybe, but dunno. > It also seems that academia is not any better than pharmaceuticals at either developing the first step or pushing something to the end. "it also seems" lacks rigour, but let that pass for now. If academia develops 85% of the drugs that are released (I'll try to find a source for that, it's from memory) then the vast majority of failure costs (85% of them) are soaked up by the taxpayer. The few that are bought up by the drugs companies, are then sold privately. Very profitable. "According to BBC News, in 2013 pharmaceutical companies enjoyed higher average profit margins than carmakers, oil and gas companies and media companies. Only banks had a profit margin comparable to Big Pharma, but Pfizer’s 42% profit margin blew every other company out of the water, prompting even a member of its own industry to say, “I wouldn’t be able to justify [those types of margins].” In 2013, five pharmaceutical companies exceeded 20% profit margins: Pfizer, Hoffman-LaRoche, AbbVie, GSK and Eli Lilly." from https://www.andruswagstaff.com/blog/big-pharma-has-higher-profit-margins-than-any-other-industry/ https://www.andruswagstaff.com/blog/big-pharma-has-higher-pr...
- aaavl2821 7y agoNearly 100% of new FDA approved drugs are developed by for profit companies. I don't know of a single case where a drug came directly from academia without another entity spending tens of millions on high risk r&d [0] It is misleading to say that the pharma industry is hugely profitable because 5 companies have high profit margins. There are thousands of pharma companies. Most will never make a profit -- they just do research. Most of these fail, the ones that succeed sell their drugs to those big pharma companies bc they can't commercialize them on their own. [0] https://troutaccess.com/index.php/snippets/details/hash/172043da53a7a847741ded09c5430d96 https://troutaccess.com/index.php/snippets/details/hash/1720...
- refurb 7y agoAre you surprised that the biggest (i.e. most successful drug companies) have the highest profit margins? What about all the companies that no longer exist because their drug failed and they went bankrupt? It's disingenuous to limit your analysis of profit to the most successful companies.
- tempguy9999 7y ago> Are you surprised that the biggest (i.e. most successful drug companies) have the highest profit margins? Not remotely surprised, because you're misrepresenting my quote. That's not what it said. Read it again.
- trentlott 7y agoBoth projects progressed to the point of running successful animal trials (n ~ 250), all of which were paid for by government grants Obviously rats aren't people, but a company obvious be edits when a molecule is discovered, synthesis optimized, and method of action/LD50 is paid for by the public before every cent of profits are privatized Even if they don't market it, they own something tthat the public paid for
- entee 7y agoWere the results published or suppressed from publication? I'm sure the University has some sort of IP department and the patent for the compound(s) would belong to the university. That patent should also be public information. If the study/compound structure has been made public in some form, I think the public has gotten its fair share. The process that will take the compound from works-in-mice to works-in-people is quite difficult and risky. Pharma companies are very good at administering those things and (usually but unfortunately not always, hello Novartis) run those programs in a manner that ensures safety as much as possible down the line. The Pharma company will spend its billion (roughly the cost per approved drug these days) and will recover many more times that if successful, but eventually the compound will become generic, and all of us will be able to get it for cheap. I think there are many many problems with pharma, and I say this as someone who is trying to start a biotech. But the fundamental process above doesn't strike me as grossly out of line, it's playing to each players strengths. The reforms I would make would be around some of the pricing excesses, some of the patent/generics loophole abuses, and to find ways to address areas that are hard to make work financially in a private setting (antibiotics for example) through some sort of public/private partnership/prize system.